Ryusei Sugimoto

447 total citations
6 papers, 369 citations indexed

About

Ryusei Sugimoto is a scholar working on Molecular Biology, Nephrology and Cell Biology. According to data from OpenAlex, Ryusei Sugimoto has authored 6 papers receiving a total of 369 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Molecular Biology, 3 papers in Nephrology and 2 papers in Cell Biology. Recurrent topics in Ryusei Sugimoto's work include Muscle metabolism and nutrition (2 papers), Parathyroid Disorders and Treatments (2 papers) and Muscle and Compartmental Disorders (1 paper). Ryusei Sugimoto is often cited by papers focused on Muscle metabolism and nutrition (2 papers), Parathyroid Disorders and Treatments (2 papers) and Muscle and Compartmental Disorders (1 paper). Ryusei Sugimoto collaborates with scholars based in Japan. Ryusei Sugimoto's co-authors include Yu Ishima, Hiroshi Watanabe, Masaki Otagiri, Motoko Tanaka, Tadashi Imafuku, Masafumi Fukagawa, Yuki Enoki, Kazutaka Matsushita, Toru Maruyama and Shunsuke Kotani and has published in prestigious journals such as Scientific Reports, Kidney International and Biochemical Pharmacology.

In The Last Decade

Ryusei Sugimoto

6 papers receiving 368 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ryusei Sugimoto Japan	6	175	148	120	67	46	6	369
Nathalie McKay France	11	96 0.5×	192 1.3×	135 1.1×	24 0.4×	18 0.4×	21	446
Qiu Gen Zhou China	9	120 0.7×	85 0.6×	106 0.9×	63 0.9×	51 1.1×	10	441
Somchit Eiam‐Ong Thailand	12	65 0.4×	120 0.8×	141 1.2×	19 0.3×	25 0.5×	29	398
Trace Thome United States	11	118 0.7×	146 1.0×	152 1.3×	35 0.5×	14 0.3×	24	401
Sanket Patel United States	14	74 0.4×	51 0.3×	146 1.2×	51 0.8×	47 1.0×	35	505
Tamara Chernichovski Israel	13	158 0.9×	73 0.5×	131 1.1×	24 0.4×	11 0.2×	28	415
Simona Racasan Romania	11	105 0.6×	80 0.5×	54 0.5×	24 0.4×	48 1.0×	19	368
Ralph A. De Fronzo United States	9	156 0.9×	72 0.5×	99 0.8×	74 1.1×	24 0.5×	9	434
Pedro Forcada Argentina	11	63 0.4×	45 0.3×	61 0.5×	78 1.2×	34 0.7×	31	424
A. Semolic Italy	16	332 1.9×	29 0.2×	119 1.0×	53 0.8×	105 2.3×	27	576

Countries citing papers authored by Ryusei Sugimoto

Since Specialization

Citations

This map shows the geographic impact of Ryusei Sugimoto's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ryusei Sugimoto with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ryusei Sugimoto more than expected).

Fields of papers citing papers by Ryusei Sugimoto

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ryusei Sugimoto. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ryusei Sugimoto. The network helps show where Ryusei Sugimoto may publish in the future.

Co-authorship network of co-authors of Ryusei Sugimoto

This figure shows the co-authorship network connecting the top 25 collaborators of Ryusei Sugimoto. A scholar is included among the top collaborators of Ryusei Sugimoto based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ryusei Sugimoto. Ryusei Sugimoto is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

6 of 6 papers shown

1.

Watanabe, Hiroshi, et al.. (2019). Effect of Serum Parathyroid Hormone on Tacrolimus Therapy in Kidney Transplant Patients: A Possible Biomarker for a Tacrolimus Dosage Schedule. Biological and Pharmaceutical Bulletin. 42(5). 786–791. 5 indexed citations

2.

Watanabe, Hiroshi, Ryusei Sugimoto, Yuki Enoki, et al.. (2017). Parathyroid hormone contributes to the down-regulation of cytochrome P450 3A through the cAMP/PI3K/PKC/PKA/NF-κB signaling pathway in secondary hyperparathyroidism. Biochemical Pharmacology. 145. 192–201. 21 indexed citations

3.

Enoki, Yuki, Hiroshi Watanabe, Tadashi Imafuku, et al.. (2017). Potential therapeutic interventions for chronic kidney disease‐associated sarcopenia via indoxyl sulfate‐induced mitochondrial dysfunction. Journal of Cachexia Sarcopenia and Muscle. 8(5). 735–747. 120 indexed citations

4.

Sugimoto, Ryusei, Hiroshi Watanabe, Yuki Enoki, et al.. (2016). Down-regulation of ABCG2, a urate exporter, by parathyroid hormone enhances urate accumulation in secondary hyperparathyroidism. Kidney International. 91(3). 658–670. 40 indexed citations

5.

Enoki, Yuki, Hiroshi Watanabe, Ryusei Sugimoto, et al.. (2016). Indoxyl sulfate potentiates skeletal muscle atrophy by inducing the oxidative stress-mediated expression of myostatin and atrogin-1. Scientific Reports. 6(1). 32084–32084. 146 indexed citations

6.

Watanabe, Hiroshi, Yoshiaki Sakaguchi, Ryusei Sugimoto, et al.. (2013). Human organic anion transporters function as a high-capacity transporter for p-cresyl sulfate, a uremic toxin. Clinical and Experimental Nephrology. 18(5). 814–820. 37 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact